Five publications from the past week:

• Clinical exome sequencing vs. usual care for hereditary colorectal cancer diagnosis: A pilot comparative effectiveness study | link
• Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial | link
• Measuring clinical utility in the context of genetic testing: a scoping review | link
• Expanding Use of Clinical Genome Sequencing and the Need for More Data on Implementation | link
• Implementing Interventions with Varying Marginal Cost-Effectiveness: An Application in Precision Medicine | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics!

No publications last week or this week. I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics!

Three publications from the past week:

• A three-year follow-up study evaluating clinical utility of exome sequencing and diagnostic potential of reanalysis | link
• Clinical Utilization, Utility, and Reimbursement for Expanded Genomic Panel Testing in Adult Oncology | link
• Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics!

Two publications from the last week:

• Efficacy and economics of targeted panel versus whole exome sequencing in 878 patients with suspected primary immunodeficiency | link
• Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values | link

I’m happy to share any other publications from this week that I’ve missed – just let me know.

One publication from the last week:

• The value of genomic sequencing in complex pediatric neurological disorders: a discrete choice experiment | link

I’m happy to share any other publications from this week that I’ve missed – just let me know.

One publication this week:

• Next generation use in Oncology, a better information on patients’ genetic profiles improved access to matched treatments and earlier NGS use show better outcomes | link

I’m happy to share any other publications from this week that I’ve missed – just let me know.